Trials / Completed
CompletedNCT00141427
Pregabalin In Partial Seizures: An Open-Label, International, Multicenter Add-On Therapy Trial.
Pregabalin In Partial Seizures (Preps) : An Open-Label, International, Multicenter Add-On Therapy Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 540 (planned)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To assess the clinical improvement (change in seizure frequency), safety and tolerability of patients with partial seizures following adjunctive therapy of pregabalin BID in addition to existing standard AEDs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pregabalin |
Timeline
- Start date
- 2004-11-01
- Completion
- 2006-05-01
- First posted
- 2005-09-01
- Last updated
- 2021-01-25
Locations
57 sites across 8 countries: Belgium, Finland, France, Netherlands, Poland, Portugal, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT00141427. Inclusion in this directory is not an endorsement.